Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 5, p. 299, doi. 10.1007/BF03262236
- By:
- Publication type:
- Article
Works matching IS 11745878 AND DT 2012 AND VI 14 AND IP 5
Results: 9
1
2
Etravirine: A Guide to Its Use in Treatment-Experienced Pediatric Patients with HIV-1 Infection in the US.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 5, p. 345, doi. 10.2165/11209720-000000000-00000
- By:
- Publication type:
- Article
3
DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa™): A Guide to Its Use in Infants.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 5, p. 337, doi. 10.2165/11210000-000000000-00000
- By:
- Publication type:
- Article
4
Adherence to Antiretroviral Therapy in HIV-Positive Adolescents in Uganda Assessed by Multiple Methods.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 5, p. 331, doi. 10.2165/11599280-000000000-00000
- By:
- Publication type:
- Article
5
Role of Leukotriene Receptor Antagonists in the Management of Pediatric Asthma.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 5, p. 317, doi. 10.2165/11599930-000000000-00000
- By:
- Publication type:
- Article
6
Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 5, p. 299, doi. 10.2165/11594740-000000000-00000
- By:
- Publication type:
- Article
7
Understanding the Value of Information from Pediatric Clinical Research.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
8
Measuring the Patient Health, Societal and Economic Benefits of US Pediatric Therapeutics Legislation.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 5, p. 283, doi. 10.2165/11633590-000000000-00000
- By:
- Publication type:
- Article
9
Professor John Andrew Vernon 1968-2012.
- Published in:
- 2012
- By:
- Publication type:
- Obituary